Qool Therapeutics, Inc. — Form D
Qool Therapeutics, Inc. of MENLO PARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-11-13. The offering totals $1.0M, of which $250K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2015-11-13
- Form: D
- Accession: 0001658096-15-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $250K
- Remaining: $750K
- Investors: 5
- Date of first sale: 2015-10-29
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-251169
Issuer
- Name: Qool Therapeutics, Inc.
- CIK: 0001658096
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1455 ADAMS DRIVE, MENLO PARK, CA, 94025
- Phone: (650) 328-1426
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Todd Brinton | Director | Santa Clara, CA |
| Beverly Huss | Director | Mountain View, CA |
| Beverly Huss | Executive Officer | Mountain View, CA |
| Fred Moll | Director | Westwood, MA |
| Amir Belson | Director | Fremont, CA |
| Amir Belson | Executive Officer | Fremont, CA |
| James Dennis | Director | Menlo Park, CA |
| Ron Dieck | Director | Menlo Park, CA |
Other filings by this issuer (2)
More